Quantitative high performance liquid chromatography tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine

被引:147
作者
Li, HW
Lawson, JA
Reilly, M
Adiyaman, M
Hwang, SW
Rokach, J
FitzGerald, GA
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Ctr Expt Therapeut, Philadelphia, PA 19104 USA
[2] Florida Inst Technol, Claude Pepper Inst, Melbourne, FL 32901 USA
[3] Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA
关键词
D O I
10.1073/pnas.96.23.13381
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Isoprostanes (iPs) are free radical catalyzed prostaglandin isomers. Analysis of individual isomers of PGF(2 alpha)-F-2-iPs-in urine has reflected lipid peroxidation in humans. However, up to 64 F-2-iPs may be formed, and it is unknown whether coordinate generation, disposition, and excretion of F2-iPs occurs in humans. To address this issue, we developed methods to measure individual members of the four structural classes of F2-iPs, using liquid chromatography/tandem mass spectrometry (LC/MS/MS), in which sample preparation is minimized. Authentic standards of F-2-iPs of classes Ill, IV, V, and VI were used to identify class-specific ions for multiple reaction monitoring. Using IPF2 alpha-VI as a model compound, we demonstrated the reproducibility of the assay in human urine. Urinary levels of all F2-iPs measured were elevated in patients with familial hypercholesterolemia. However, only three of eight F-2-iPs were elevated in patients with congestive heart failure, compared with controls. Paired analyses by GC/MS and LC/MS/MS of IPF2 alpha-VI in hypercholesterolemia and of 8,12-iso-iPF(2 alpha)-VI in congestive heart failure were highly correlated. This approach will permit high throughput analysis of multiple iPs in human disease.
引用
收藏
页码:13381 / 13386
页数:6
相关论文
共 50 条
[1]   Total synthesis of a novel isoprostane IPF2 alpha-I and its identification in biological fluids [J].
Adiyaman, M ;
Lawson, JA ;
Hwang, SW ;
Khanapure, SP ;
FitzGerald, GA ;
Rokach, J .
TETRAHEDRON LETTERS, 1996, 37 (28) :4849-4852
[2]   First total synthesis of isoprostane IPF2 alpha-III [J].
Adiyaman, M ;
Li, HW ;
Lawson, JA ;
Hwang, SW ;
Khanapure, SP ;
FitzGerald, GA ;
Rokach, J .
TETRAHEDRON LETTERS, 1997, 38 (19) :3339-3342
[3]  
AWAD JA, 1993, J BIOL CHEM, V268, P4161
[4]   Quantitation of SR 27417 in human plasma using electrospray liquid chromatography tandem mass spectrometry: A study of ion suppression [J].
Buhrman, DL ;
Price, PI ;
Rudewicz, PJ .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1996, 7 (11) :1099-1105
[5]   Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway [J].
Chen, Y ;
Morrow, JD ;
Roberts, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10863-10868
[6]   Identification and measurement of endogenous β-oxidation metabolites of 8-epi-prostaglandin F2α [J].
Chiabrando, C ;
Valagussa, A ;
Rivalta, C ;
Durand, T ;
Guy, A ;
Zuccato, E ;
Villa, P ;
Rossi, JC ;
Fanelli, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) :1313-1319
[7]  
CONTADO MJ, 1989, ADV MASS SPECTROM B, V11, P1034
[8]  
Davì G, 1999, CIRCULATION, V99, P224
[9]   8-Epi PGF(2 alpha) generation during coronary reperfusion - A potential quantitative marker of oxidant stress in vivo [J].
Delanty, N ;
Reilly, MP ;
Pratico, D ;
Lawson, JA ;
McCarthy, JF ;
Wood, AE ;
Ohnishi, ST ;
Fitzgerald, DJ ;
FitzGerald, GA .
CIRCULATION, 1997, 95 (11) :2492-2499
[10]  
Elmhurst JL, 1997, J PHARMACOL EXP THER, V282, P1198